Sorafenib in the management of metastatic renal cell carcinoma

PURPOSE: Sorafenib represents one of the two standards of care for patients with metastatic renal cell carcinoma (mrcc). In the present review, we provide information regarding the use of sorafenib in first and second lines. We also describe results for dose escalation strategies. Finally, we provid...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Guevremont, C., Jeldres, C., Perrotte, P., Karakiewicz, P.I.
Format: Artigo
Jezik:Inglês
Izdano: Multimed Inc. 2009
Teme:
Urologic Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687798/
https://ncbi.nlm.nih.gov/pubmed/19478894
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki